BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8026253)

  • 1. Idiopathic gastric acid hypersecretion. Comparison with Zollinger-Ellison syndrome.
    Collen MJ; Jensen RT
    Dig Dis Sci; 1994 Jul; 39(7):1434-40. PubMed ID: 8026253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease.
    Blonski WC; Katzka DA; Lichtenstein GR; Metz DC
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):441-4. PubMed ID: 15756097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature.
    Roy PK; Venzon DJ; Feigenbaum KM; Koviack PD; Bashir S; Ojeaburu JV; Gibril F; Jensen RT
    Medicine (Baltimore); 2001 May; 80(3):189-222. PubMed ID: 11388095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zollinger-Ellison syndrome. Relation to Helicobacter pylori-associated chronic gastritis and gastric acid secretion.
    Fich A; Talley NJ; Shorter RG; Phillips SF
    Dig Dis Sci; 1991 Jan; 36(1):10-4. PubMed ID: 1984995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and secretin as provocative stimuli in the Zollinger-Ellison syndrome.
    Mihas AA; Hirschowitz BI; Gibson RG
    Digestion; 1978; 17(1):1-10. PubMed ID: 627316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
    Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
    Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
    Banasch M; Schmitz F
    Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of gastric analysis with particular reference to the diagnosis of Zollinger-Ellison syndrome.
    Ishimori A; Miura Y; Sakurada H; Yamagata S; Tsuda K
    Tohoku J Exp Med; 1975 Sep; 117(1):15-21. PubMed ID: 1188927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
    Roy PK; Venzon DJ; Shojamanesh H; Abou-Saif A; Peghini P; Doppman JL; Gibril F; Jensen RT
    Medicine (Baltimore); 2000 Nov; 79(6):379-411. PubMed ID: 11144036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric acid secretion and diagnosis of Zollinger-Ellison syndrome.
    Lewin MR; Stagg BH; Clark CG
    Br Med J; 1973 Apr; 2(5859):139-41. PubMed ID: 4699593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucagon on serum gastrin. II. Studies in pernicious anaemia and the Zollinger-Ellison syndrome.
    Korman MG; Soveny C; Hansky J
    Gut; 1973 Jun; 14(6):459-61. PubMed ID: 4719212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of urogastrone in the Zollinger-Ellison syndrome.
    Elder JB; Gillespie IE; Ganguli PC; Delamore WI; Gregory H
    Lancet; 1975 Sep; 2(7932):424-7. PubMed ID: 51236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor.
    Friesen SR; Tomita T
    Ann Surg; 1981 Oct; 194(4):481-93. PubMed ID: 7283508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Zollinger-Ellison syndrome and mismeasurement of gastrin.
    Rehfeld JF; Gingras MH; Bardram L; Hilsted L; Goetze JP; Poitras P
    Gastroenterology; 2011 May; 140(5):1444-53. PubMed ID: 21315717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zollinger-Ellison syndrome type 1: clinical and pathological correlations in a case.
    Cowley DJ; Dymock IW; Boyes BE; Wilson RY; Stagg BH; Lewin MR; Polak JM; Pearse AG
    Gut; 1973 Jan; 14(1):25-9. PubMed ID: 4571070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of serum gastrin levels in Zollinger-Ellison syndrome. Studies with two antisera to gastrin.
    Ivey KJ; Hansky J
    Am J Dig Dis; 1975 Jun; 20(6):513-17. PubMed ID: 1130377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the Zollinger-Ellison syndrome in pregnancy.
    Stewart CA; Termanini B; Sutliff VE; Corleto VD; Weber HC; Gibril F; Jensen RT
    Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):224-33. PubMed ID: 9024119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zollinger-Ellison syndrome: current concepts and management.
    Jensen RT; Gardner JD; Raufman JP; Pandol SJ; Doppman JL; Collen MJ
    Ann Intern Med; 1983 Jan; 98(1):59-75. PubMed ID: 6336642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
    Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
    Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.